Annual & Half Year Reports
Latest News
-
Submission of new Phase III study protocol to FDA for expanded indication of XENOVIEW
12 August 2025 -
Block Listing Six Monthly Return
24 July 2025 -
Promotion & Sales Representative Agreement
24 June 2025
About Us
Latest Annual Report
Investor Alert
Sign up for Email Alerts